Evercore ISI raised the firm’s price target on Henry Schein (HSIC) to $90 from $83 and keeps an Outperform rating on the shares. The dental market is stabilizing and operational improvements are underway, while the anticipation of a new CEO announcement in Q4 adds to the momentum, the analyst tells investors.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HSIC: